Sandbox:Sahar: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 2: Line 2:
|+  
|+  
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Disease Name}}  
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Disease Name}}  
! style="background: #4479BA; width: 150px;" | Causes
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Causes}}
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| History and Symptoms}}
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| History and Symptoms}}
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Physical Examination Findings}}
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Physical Examination Findings}}
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG Characteristics}}
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG Characteristics}}
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG view}}
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG view}}
!Prognosis
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Prognosis}}
|-
|-
! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Ventricular tachycardia
! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Ventricular tachycardia
Line 15: Line 15:
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Ventricular fibrillation
! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Ventricular fibrillation
Line 23: Line 23:
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Asystole
! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Asystole
Line 31: Line 31:
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Pulseless electrical activity
! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Pulseless electrical activity
Line 39: Line 39:
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Pulmonary embolism
! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Pulmonary embolism
Line 47: Line 47:
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="left" |
! style="padding: 5px 5px; background: #DCDCDC;" align="left" |
Line 55: Line 55:
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
! style="padding: 5px 5px; background: #DCDCDC; " align="left" |
! style="padding: 5px 5px; background: #DCDCDC; " align="left"|
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
Line 63: Line 64:
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|
|}
|}
<references />
<references />

Revision as of 18:37, 16 January 2020

Disease Name Causes History and Symptoms Physical Examination Findings ECG Characteristics ECG view Prognosis
Ventricular tachycardia
Ventricular fibrillation
Asystole
Pulseless electrical activity
Pulmonary embolism


Disease Name Age of Onset Gender Preponderance Signs/Symptoms Imaging Feature(s) Macroscopic Feature(s) Microscopic Feature(s) Laboratory Findings(s) Other Feature(s) ECG view
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:Sahar&oldid=1595398"